Electromed Stock Price, News & Analysis (NYSEAMERICAN:ELMD)

$6.37
-0.02 (-0.31 %)
(As of 09/24/2019 05:32 AM ET)
Today's Range
$6.37
Now: $6.37
$6.37
50-Day Range N/A
52-Week Range
$4.75
Now: $6.37
$7.33
Volume100 shs
Average Volume11,818 shs
Market Capitalization$53.77 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:ELMD
Previous SymbolNYSEMKT:ELMD
CUSIPN/A
Phone+1-952-7589299

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees132
Market Cap$53.77 million
Next Earnings Date11/12/2019 (Estimated)
OptionableNot Optionable

Receive ELMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.


Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions

What is Electromed's stock symbol?

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSEAMERICAN:ELMD) posted its earnings results on Tuesday, August, 27th. The medical equipment provider reported $0.13 earnings per share (EPS) for the quarter. The medical equipment provider had revenue of $8.60 million for the quarter. View Electromed's Earnings History.

When is Electromed's next earnings date?

Electromed is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Electromed.

Has Electromed been receiving favorable news coverage?

News articles about ELMD stock have been trending somewhat negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Electromed earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Electromed.

Are investors shorting Electromed?

Electromed saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 2,400 shares, an increase of 50.0% from the July 31st total of 1,600 shares. Based on an average daily volume of 7,400 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the shares of the company are sold short. View Electromed's Current Options Chain.

Who are some of Electromed's key competitors?

What other stocks do shareholders of Electromed own?

Who are Electromed's key executives?

Electromed's management team includes the folowing people:
  • Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 63)
  • Mr. Jeremy T. Brock CPA, CFO, Principal Accounting Officer & Financial Controller (Age 40)
  • Mr. Bud Reeves, VP of Sales
  • Mr. William J. George J.D., Sec. (Age 70)
  • Ms. Kathryn Thompson, VP of Reimbursement

Who are Electromed's major shareholders?

Electromed's stock is owned by a number of of retail and institutional investors. Top institutional investors include Teton Advisors Inc. (1.90%), Renaissance Technologies LLC (1.22%), White Pine Capital LLC (1.03%), BlackRock Inc. (0.39%) and Susquehanna International Group LLP (0.28%). Company insiders that own Electromed stock include Red Oak Partners, Llc and Stephen H Craney. View Institutional Ownership Trends for Electromed.

Which major investors are selling Electromed stock?

ELMD stock was sold by a variety of institutional investors in the last quarter, including White Pine Capital LLC. View Insider Buying and Selling for Electromed.

Which major investors are buying Electromed stock?

ELMD stock was acquired by a variety of institutional investors in the last quarter, including Teton Advisors Inc., Susquehanna International Group LLP, Renaissance Technologies LLC and BlackRock Inc.. View Insider Buying and Selling for Electromed.

How do I buy shares of Electromed?

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Electromed's stock price today?

One share of ELMD stock can currently be purchased for approximately $6.37.

How big of a company is Electromed?

Electromed has a market capitalization of $53.77 million. Electromed employs 132 workers across the globe.View Additional Information About Electromed.

What is Electromed's official website?

The official website for Electromed is http://smartvest.com/.

How can I contact Electromed?

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.


MarketBeat Community Rating for Electromed (NYSEAMERICAN ELMD)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  134 (Vote Outperform)
Underperform Votes:  176 (Vote Underperform)
Total Votes:  310
MarketBeat's community ratings are surveys of what our community members think about Electromed and other stocks. Vote "Outperform" if you believe ELMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/24/2019 by MarketBeat.com Staff

Featured Article: Holder of Record

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel